Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMYAXNM)

Drug Name

SRK-015 Drug Info

Synonyms

Apitegromab

Indication

Disease Entry	ICD 11	Status	REF
Spinal muscular atrophy	8B61	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Myostatin (MSTN)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AAV1-FS344	DMAPUZY	Duchenne dystrophy	8C70	Phase 1/2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT03921528) An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Scholar Rock.
3	Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Sci Transl Med. 2009 November 11; 1(6): 6ra15.